Pet Health Booms vs Cattle Revenue Slumps Analysts Panic
Elanco’s Q1 2026 earnings suggest next quarter will see a modest 2.1% earnings per share increase despite a 12% drop in cattle disease treatment revenue. Pet Health Highlights in Elanco Q1 2026 Earnings Key Takeaways * Pet health grew 4.7% YoY to $1.1 B. * Segment accounts for